24/04/2003 (Agence Europe) - The European Commission has finally just adopted its amended draft directive on medicines for human consumption. The Commission has accepted a certain number of amendments adopted by the European Parliament in October's first reading, like, for example, the re-evaluation of full market approval after five years (in its initial proposal the first authorisation was definitive). On the other hand, the Commission maintains the ten years protection for clinical data,...